Trials / Not Yet Recruiting
Not Yet RecruitingNCT07394270
Effect of Add-on L-Arginine Therapy on Heart Failure Patients
Effect of Add-on L-Arginine Therapy on Clinical Outcome of Heart Failure Patients: A Randomized- Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- German University in Cairo · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
Heart failure is considered one of the greatest challenges globally. There are various treatment strategies for heart failure. L-Arginine is an amino acid that was found to have beneficial effect on vasculature. This study aims to study the benefits and side effects of using L-arginine on the patients with ejection fraction \<40%
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L-Arginine Powder | L-arginine 3 gm sachets are used twice daily |
| DRUG | Placebo | 2 sachets of placebo are administered per day |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2027-03-01
- Completion
- 2027-07-01
- First posted
- 2026-02-06
- Last updated
- 2026-02-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07394270. Inclusion in this directory is not an endorsement.